Olema Pharmaceuticals OLMA
NASDAQ OLMA
$7.26 -0.01 (-0.14%)
As of: Nov 11, 2026 · 11:03 AM EST

Olema Pharmaceuticals (OLMA) Net Equity Issued and Repurchased (2020 - 2026)

Updated

Olema Pharmaceuticals (OLMA) reported Net Equity Issued and Repurchased of -$4.19 million for Q2 2026, compared with $234,000 a year earlier.

Analysis

Olema Pharmaceuticals (OLMA) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Olema Pharmaceuticals' Net Equity Issued and Repurchased came in at $12.16 million, down 95.0% year-over-year; for FY2025, it was $8.39 million, down 96.6% from FY2024.

  • Net Equity Issued and Repurchased has a five-year compound annual growth rate of -48.0% (FY2020 to FY2025).
  • By year, Net Equity Issued and Repurchased came in at $243.5 million in FY2024 (+87.7%), $129.74 million in FY2023, $146,000 in FY2022 (-78.2%) and $670,000 in FY2021 (-99.7%).
  • The Q2 2026 figure ranks as the lowest quarterly Net Equity Issued and Repurchased in data going back to Q1 2020.
  • Year over year, Net Equity Issued and Repurchased gained in 1 of the last five quarters, with an average decline of 17.5%.
  • The high point for year-over-year Net Equity Issued and Repurchased in five years was Q1 2023 (growth of 566.7%); the low point was Q3 2024 (a decline of 99.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $8.43 million (Q1 2026), $7.88 million (Q4 2025) and $41,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Olema Pharmaceuticals 734.94 Mn -1.15 Bn - -4.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -4.24 Mn
Jun 30, 2026 -3.54 Mn
Mar 31, 2026 8.43 Mn
Dec 31, 2025 8.16 Mn
Sep 30, 2025 41,000.00
Jun 30, 2025 982,000.00
Mar 31, 2025 236,000.00
Dec 31, 2024 244.30 Mn
Sep 30, 2024 92,000.00
Jun 30, 2024 719,000.00
Mar 31, 2024 920,000.00
Dec 31, 2023 523,000.00
Sep 30, 2023 130.63 Mn
Jun 30, 2023 2.04 Mn
Mar 31, 2023 220,000.00
Dec 31, 2022 273,000.00
Sep 30, 2022 106,000.00
Jun 30, 2022 64,000.00
Mar 31, 2022 33,000.00
Dec 31, 2021 818,000.00
API Access

Olema Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=OLMA&period=max&api_key=YOUR_API_KEY